Drug lookup
Drug reference

Rasburicase

Antidote · Antihyperuricemic

AntidoteAntihyperuricemic
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
2 major
SEVERE in our sources
PREGNANCY
Manufacturer advises avoid—no information available.
FDA category + note
Top interactions
  • Nitrous AcidSevereDatabaseDDInter
  • PrilocaineSevereDatabaseDDInter

Mechanism

Rasburicase is a recombinant urate oxidase enzyme. It catalyzes the enzymatic oxidation of uric acid into allantoin, a more soluble and readily excretable inactive metabolite. This action rapidly reduces plasma-uric acid concentration.

Indications

Prophylaxis and treatment of acute hyperuricaemia, before and during initiation of chemotherapy, in patients with haematological malignancy and high tumour burden at risk of rapid lysisprevention and treatment of hyperuricemiaInitial management of elevated plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and significant hyperuricemia

Dosing

Adult
BY INTRAVENOUS INFUSION: 200 micrograms/kg once daily for up to 7 days according to plasma-uric acid concentration

Contraindications

  • G6PD deficiency
  • Atopic allergies
  • Glucose-6-phosphate dehydrogenase deficiency

Side effects

Common
Diarrhoeafeverheadachenauseaskin reactionsvomitingAbdominal painConstipationDiarrheaMucositis
Serious
  • Bronchospasm
  • haemolysis
  • haemolytic anaemia
  • hypersensitivity
  • hypotension
  • methaemoglobinaemia
  • seizure
  • Muscle contractions involuntary
  • hemolytic anemia
  • methemoglobinemia
  • Hemolysis in G6PD-deficient patients
  • Acute renal failure
  • Anaphylaxis
  • Activity-limiting antibodies (limit use for chronic gout)

Pregnancy & lactation

Pregnancy

Manufacturer advises avoid—no information available.

Lactation

Manufacturer advises avoid—no information available.

Drug interactions

Nitrous Acid
Severe
Database

Clinical effect not specified

Source: DDInter

Prilocaine
Severe
Database

Clinical effect not specified

Source: DDInter

6 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Antidote drugs

Ask House about Rasburicase

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e, Harrison 22e, Katzung, BNF·Verified: 2026-05-10 · House clinical team